Dr. Parvez Mantry, MD
Claim this profileThe Liver Institute at Methodist Dallas Medical Center
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
19 reported clinical trials
26 drugs studied
About Parvez Mantry, MD
Education:
- Earned an MD from the University of Bombay, India.
- Completed Residency at Metropolitan Hospital Center, New York Medical College.
- Undertook a Fellowship in Gastroenterology at the University of Rochester School of Medicine, New York.
Experience:
- Board certified in Internal Medicine, Gastroenterology, and Transplant Hepatology.
- Serves as Medical Director for Liver Institute Research and the Hepatobiliary Tumor Program at The Liver Institute at Methodist Dallas Medical Center.
- Led a pioneering team in performing fully robotic Whipple and liver resection procedures in North Texas.
Area of expertise
1Non-alcoholic Fatty Liver Disease
Stage I
Stage II
2Fatty Liver Disease
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Parvez Mantry, MD is currently running
HM15211
for Non-alcoholic Steatohepatitis (NASH)
This trial is testing a medication called HM15211 to see if it can help people with a liver disease called NASH. The study will check if the medication is safe and effective over a period of time.
Recruiting0 awards Phase 23 criteria
Lanifibranor
for Nonalcoholic Steatohepatitis (NASH)
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Recruiting1 award Phase 31 criteria
More about Parvez Mantry, MD
Clinical Trial Related4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Parvez Mantry, MD has experience with
- Placebo
- INT-787
- Nivolumab
- Ipilimumab
- Lenvatinib
- Sorafenib
Breakdown of trials Parvez Mantry, MD has run
Non-alcoholic Fatty Liver Disease
Fatty Liver Disease
Cholangitis
Liver Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Parvez Mantry, MD specialize in?
Parvez Mantry, MD focuses on Non-alcoholic Fatty Liver Disease and Fatty Liver Disease. In particular, much of their work with Non-alcoholic Fatty Liver Disease has involved Stage I patients, or patients who are Stage II.
Is Parvez Mantry, MD currently recruiting for clinical trials?
Yes, Parvez Mantry, MD is currently recruiting for 6 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Parvez Mantry, MD has studied deeply?
Yes, Parvez Mantry, MD has studied treatments such as Placebo, INT-787, Nivolumab.
What is the best way to schedule an appointment with Parvez Mantry, MD?
Apply for one of the trials that Parvez Mantry, MD is conducting.
What is the office address of Parvez Mantry, MD?
The office of Parvez Mantry, MD is located at: The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas 75203 United States. This is the address for their practice at the The Liver Institute at Methodist Dallas Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.